Strength
1 mg/mL
Manufacturer
CMP Pharma, Inc.NDC
46287003515
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
AMLODIPINEApproval Type
New Drug (NDA)
FDA Application
NDA214439On Market Since
4/15/2022
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 360 MG CAPSULE
Brand
00187261630•Bausch Health US LLC
$2.7628
per EA
TIAZAC ER 360 MG CAPSULE
Brand
00187261690•Bausch Health US LLC
$2.7628
per EA
CARDIZEM LA 120 MG TABLET
Brand
00187204530•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 120 MG TABLET
Brand
00187204590•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 180 MG TABLET
Brand
00187204630•Bausch Health US LLC
$3.8314
per EA
CARDIZEM LA 180 MG TABLET
Brand
00187204690•Bausch Health US LLC
$3.8314
per EA
KATERZIA 1 MG/ML SUSPENSION
Brand
52652500101•Azurity Pharmaceuticals Inc.
$4.1914
per ML
CARDIZEM LA 240 MG TABLET
Brand
00187204730•Bausch Health US LLC
$4.3424
per EA